SUNDAY, April 15 (HealthDay News) — A large international group of researchers has identified 32 new genetic regions linked to fractures and osteoporosis.
Variations in these regions could offer protection from, or greater risk for, bone-weakening disease, the investigators reported in a new study published in the April 15 online edition of Nature Genetics.
MONDAY, March 19 (HealthDay News) — The first generic versions of the once-monthly osteoporosis drug Boniva (ibandronate) have been approved by the U.S. Food and Drug Administration.
Osteoporosis, characterized by a thinning of the bones, is the most common type of bone disease, the agency said in a news release Monday. More common in postmenopausal women, it increases the risk of fracture, especially of the hip, spine and wrist.
THURSDAY, February 16, 2012 (Health.com) — It sounds like something out of a sci-fi movie: A patient visits a doctor’s office and, after a brief surgical procedure, walks away with a microchip under her skin that delivers medication in precisely timed and measured doses.
That scenario doesn’t seem so futuristic anymore. Researchers at the Massachusetts Institute of Technology (MIT) announced today that they have successfully completed the first trial of a drug-releasing microchip in humans. The results were published on the website of the journal Science Translational Medicine. Read More
TUESDAY, Feb. 7 (HealthDay News) –
Heart failure is linked to thinning of the bones and an increased risk of fractures, a new study indicates.
The findings suggest that aggressive screening for osteoporosis may be important for heart failure patients, the researchers said.
They looked at data from about 45,500 adults who underwent bone mineral density testing for the first time and were followed for up to 10 years. Of those people, 1,841 had recent-onset heart failure.
MONDAY, September 26, 2011 (Health.com) — Women age 65 and older who fracture a hip are much more likely to die from any cause during the following year than they would be if they had avoided injury, a new study suggests.
The increased risk of death associated with hip fractures was especially dramatic among younger women. In the 65- to 69-year-old age group, the odds of death were five times higher for women in a post-fracture year than they were for non-injured women of the same age, the study found. Read More
By Kathleen Doheny
HealthDay Reporter
SUNDAY, Sept. 25 (HealthDay News) — The bone drug Zometa, once considered a promising weapon to reduce the risk of breast cancer recurrence, should not be used routinely in treatment of the disease, researchers say.
In a new study of breast cancer patients, Zometa (zoledronic acid) did not increase disease-free survival overall, and it appeared to raise the risk of a serious side effect, said study co-author Dr. Robert Coleman, a professor of medical oncology at the University of Sheffield in England.
By Steven Reinberg
HealthDay Reporter
FRIDAY, Sept. 9 (HealthDay News) — U.S. Food and Drug Administration advisers recommended Friday that osteoporosis drugs such as Fosamax, Actonel, Boniva and Reclast come with revised labels, clarifying how long a patient should take a drug before potential health risks set in.
The drugs, known as bisphosphonates, are taken to prevent fractures related to postmenopausal osteoporosis. But researchers have linked long-term use with a small risk of unusual fractures of the thigh bone, death of the jawbone (osteonecrosis of the jaw) and possibly esophageal cancer.
WEDNESDAY, Aug. 17 (HealthDay News) — Although not life-threatening, sprains and strains account for more than one-third of lower leg injuries treated in U.S. emergency departments, according to a new study.
Alternative approaches to treatment, such as an emergency hotline or scheduled doctor appointments, would spare valuable time and emergency department resources, researchers from Massachusetts General Hospital in Boston, said in the report, recently published online in Clinical Orthopaedics and Related Research.
TUESDAY, July 26 (HealthDay News) — In the days after they start taking non-SSRI (selective serotonin reuptake inhibitor) antidepressants, such as bupropion or venlafaxine, nursing home residents are at significantly greater risk for falls, according to a new study.
Researchers found the increased risk for falls also applies to those who had a dosage increase of their current prescription.
TUESDAY, June 14 (HealthDay News) — The first ceramic-on-metal total hip replacement system has been approved by the U.S. Food and Drug Administration.
The Pinnacle Complete Acetabular Hip System, combining a ceramic ball and a metal socket, has been sanctioned for people with osteoarthritis, the agency said in a news release.
| Text Size: |  |
|
